Pharmacology, Toxicology and Pharmaceutical Science
Opiate
100%
Cohort Study
68%
Chronic Myeloid Leukemia
50%
Imatinib
41%
Tramadol
37%
Psoriasis
33%
Disease
22%
Prevalence
20%
Gabapentinoid
19%
Defined Daily Dose
19%
Drug Utilization
18%
Psychotropic Agent
18%
Adverse Event
17%
Cross-Sectional Study
17%
Morphine
16%
Case-Control Study
16%
Infection
16%
Psoriatic Arthritis
16%
Randomized Controlled Trial
16%
Long Term Survival
11%
Malignant Neoplasm
10%
Mortality Rate
7%
Cancer Pain
5%
Duragesic
5%
Medicine and Dentistry
Cohort Analysis
35%
Psoriasis
33%
Chronic Myelogenous Leukemia
33%
Imatinib
25%
Hazard Ratio
19%
Tramadol
16%
Infection
16%
Hormone Therapy
16%
Breast Cancer
16%
Frailty
16%
Estrogen Receptor
16%
Opiate
16%
Quality of Life Measure
16%
Meta-Analysis
16%
Randomized Controlled Trial
16%
Long Term Survival
11%
Gene Linkage
10%
Drug Therapy
9%
Scoring System
8%
Health Care Cost
7%
Treatment Response
6%
Charlson Comorbidity Index
6%
Overall Survival
6%
High Risk Population
6%
Nursing and Health Professions
Confidence Interval
36%
Opiate
33%
Imatinib
33%
Tramadol
33%
Cohort Analysis
27%
National Health Insurance
18%
Chronic Myeloid Leukemia
16%
Primary Medical Care
16%
Cross-Sectional Study
16%
Clinical Outcome
16%
Infection
16%
Psoriasis
16%
Meta Analysis
16%
Hazard Ratio
13%
Morphine
7%
Malignant Neoplasm
7%
Odds Ratio
7%
Drug Therapy
6%
Duragesic
5%
Cancer Pain
5%